Entheon Biomedical Corp (ENBI)

CSE
0.05
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.05/0.06
  • Day's Range:
    0.05 - 0.05

ENBI Overview

Prev. Close
0.06
Day's Range
0.05-0.05
Revenue
42K
Open
0.05
52 wk Range
0.04-0.71
EPS
-0.115
Volume
0
Market Cap
2.95M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
41,869
P/E Ratio
-0.433
Beta
1.21
1-Year Change
-84.85%
Shares Outstanding
59,089,266
Next Earnings Date
-
What is your sentiment on Entheon Biomedical?
or
Vote to see community's results!

Entheon Biomedical Corp Company Profile

Entheon Biomedical Corp Company Profile

Employees
4
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA29383X1033
  • CUSIP:29383X103

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyNeutralStrong Sell
Technical IndicatorsNeutralNeutralNeutralBuyStrong Sell
SummaryBuyBuyNeutralNeutralStrong Sell